Yahoo
LSE - Delayed Quote GBp

Eden BioSolutions plc (EDEN.L)

3.5900 +0.4400 (+13.97%)
As of 11:30:38 AM GMT. Market Open.
Chart Range Bar
Loading chart for EDEN.L
  • Previous Close 3.1500
  • Open 3.3000
  • Bid 3.5000 x --
  • Ask 3.7000 x --
  • Day's Range 3.1000 - 3.7000
  • 52 Week Range 1.9000 - 5.0000
  • Volume 1,605,042
  • Avg. Volume 646,750
  • Market Cap (intraday) 28.841M
  • Beta (5Y Monthly) 1.79
  • PE Ratio (TTM) --
  • EPS (TTM) -0.0000
  • Earnings Date --
  • Forward Dividend & Yield -- (0.00%)
  • Ex-Dividend Date --
  • 1y Target Est 20.00

Eden BioSolutions plc, together with its subsidiaries, biopesticides and plastic-free encapsulation technology for use in the global crop protection, animal health, and consumer products industries in Europe and the United Kingdom. The company offers foliar disease and insect control, open field and greenhouses, soil pests, post-harvest shelf-life extension, and seed treatments under the Mevalone and Cedroz brands for crop protection applications. It also provides consumer products, such as head-lice treatment, deodorants, odour neutralizer, and fragrances, as well as food flavourings and active ingredients; and animal health products comprising companion animal, biocontrol, parasite treatments, and insect sprays. Eden BioSolutions plc was formerly known as Eden Research plc and changed its name to Eden BioSolutions plc in September 2026. The company was incorporated in 1995 and is headquartered in Abingdon, the United Kingdom.

www.edenresearch.com

23

Full Time Employees

March 31

Fiscal Year Ends

Recent News

View More

Performance Overview

Trailing total returns as of 11/2/2026, which may include dividends or other distributions. Benchmark is FTSE 100 (^FTSE) .

YTD Return

EDEN.L
35.47%
FTSE 100 (^FTSE)
8.07%

1-Year Return

EDEN.L
43.60%
FTSE 100 (^FTSE)
10.45%

3-Year Return

EDEN.L
17.47%
FTSE 100 (^FTSE)
44.13%

5-Year Return

EDEN.L
57.01%
FTSE 100 (^FTSE)
47.54%

Analyst Insights

View More

Analyst Price Targets

20.00
20.00 Average
3.5900 Current
20.00 High

Statistics

View More

Valuation Measures

Annual
  • Market Cap

  • Enterprise Value

  • Trailing P/E

  • Forward P/E

  • PEG Ratio (current)

  • Price/Sales (ttm)

  • Price/Book (mrq)

  • Enterprise Value/Revenue

  • Enterprise Value/EBITDA

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -50.43%

  • Return on Assets (ttm)

    --

  • Return on Equity (ttm)

    --

  • Revenue (ttm)

    3.88M

  • Net Income Avi to Common (ttm)

    -1.96M

  • Diluted EPS (ttm)

    -0.0000

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    1.85M

  • Total Debt/Equity (mrq)

    5.39%

  • Levered Free Cash Flow (ttm)

    --

Company Insights

Research Reports

View More

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: